Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (1): 48-53. doi: 10.19723/j.issn.1671-167X.2022.01.008

Previous Articles     Next Articles

Comparison of initial periodontal therapy and its correlation with white blood cell level in periodontitis patients with or without diabetes mellitus

XU Xin-ran,HUO Peng-cheng,HE Lu(),MENG Huan-xin,ZHU Yun-xuan,JIN Dong-si-qi   

  1. Department of Periodontology, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
  • Received:2021-10-10 Online:2022-02-18 Published:2022-02-21
  • Contact: Lu HE E-mail:helubj@tom.com

RICH HTML

   

PDF (PC)

Abstract:

Objective: To compare the clinical efficacy of initial periodontal therapy in periodontitis patients with or without type 2 diabetes mellitus and its correlation with white blood cell counts. Methods: In this study, 32 chronic periodontitis patients without systemic disease (CP group) and 27 chronic periodontitis patients with type 2 diabetes mellitus (CP+DM group) were enrolled. At admission, all the patients went through periodontal examination and fasting blood examination(baseline). Probing depth (PD), attachment loss (AL), bleeding index (BI), plaque index (PLI), white blood cells (WBC) counts and fasting blood glucose (FBG) were recorded respectively, while hemoglobin A1c (HbA1c) was recorded only in CP+DM group. After that, initial periodontal therapy was performed. All the tests were repeated 3 and 6 months after treatment. The changes of periodontal clinical indexes and WBC levels were compared between the two groups before and after treatment, and the correlation between WBC and periodontal clinical indexes and glucose metabolism indexes were analyzed by generalized linear mixed model. Results: At baseline, the periodontal inflammation and destruction were similar in CP and CP+DM group, but the WBC level was significantly higher in CP+DM groups [(6.01±1.26)×109/L vs. (7.14±1.99)×10 9/L, P=0.01]. After 3 and 6 months of initial periodontal therapy, the mean PD, AL, BI, and PLI in CP+DM and CP groups were significantly lower than the baseline, and the PD in CP+DM group was further decreased by 6 months compared with 3 months [(3.33±0.62) mm vs. (3.61±0.60) mm, P<0.05]. However, none of these periodontal indexes showed significant difference between the two groups by 3 or 6 months. In CP+DM group, HbA1c at 3 months and 6 months were significantly lower than the baseline [(7.09±0.79)% vs. (7.64±1.16)%, P<0.05; (7.06±0.78)% vs. (7.64±1.16)%, P<0.05], and FBG was significantly lower than the baseline by 6 months [(7.35±1.14) mmol/L vs. (8.40±1.43) mmol/L, P<0.05]. The WBC level in CP group was significantly lower than the baseline level by 3 months [(5.35±1.37)×10 9/L vs. (6.01±1.26)×10 9/L, P<0.05], while that in CP+DM group was significantly lower than the baseline level by 6 months [(6.00±1.37)×10 9/L vs. (7.14±1.99)×10 9/L, P<0.05]. The analysis of genera-lized linear mixed model showed that WBC level was significantly positively correlated with PD and FBG (P<0.05). Conclusion: Initial periodontal therapy can effectively improve the periodontal clinical status of patients with or without type 2 diabetes mellitus, and have benefits on glycemic control in diabetic patients. However, the response of periodontal indexes and WBC level to initial therapy were relatively delayed in diabetic patients. WBC plays an important role in the correlation between diabetes mellitus and periodontitis.

Key words: Periodontitis, Diabetes mellitus, type 2, Dental scaling, Periodontal index

CLC Number: 

  • R781.4

Table 1

General characteristic and clinical indexes at baseline of patients in CP and CP+DM groups"

Items CP group
(n=32)		 CP+DM group
(n=27)		 P
Age/years 47.16±5.35 54.22±7.87 <0.001
Male 13 (40.6) 18 (66.7) 0.046
BMI/(kg/m2) 23.48±2.11 24.25±2.26 0.182
WHR 0.88±0.06 0.88±0.03 0.614
PD/mm 4.68±0.59 4.63±0.95 0.821
AL/mm 4.43±1.20 4.56±0.99 0.669
BI 3.20±0.63 2.90±0.73 0.089
PLI 2.97±0.12 2.85±0.21 0.009
WBC/(×109/L) 6.01±1.26 7.14±1.99 0.010
FBG/(mmol/L) 5.20±0.35 8.40±1.43 <0.001
HbA1c/% - 7.64±1.16

Table 2

Influence of initial periodontal therapy on periodontal indexes, glycemic parameters and WBC levels"

Items Baseline 3 months 6 months Δ3 months Δ6 months
PD/mm
CP group 4.68±0.59 3.62±0.64* 3.47±0.57* 1.07±0.63 1.20±0.68
CP+DM group 4.63±0.95 3.61±0.60* 3.33±0.62*§ 1.02±0.86 1.30±0.84
AL/mm
CP group 4.43±1.20 3.87±1.07* 3.58±0.81*§ 0.56±0.66 0.85±0.66
CP+DM group 4.56±0.99 3.79±0.83* 3.76±0.86* 0.77±0.85 0.80±0.62
BI
CP group 3.20±0.63 2.09±0.61* 2.03±0.55* 1.12±0.82 1.18±0.82
CP+DM group 2.90±0.73 1.97±0.56* 1.84±0.42* 0.93±0.85 1.06±0.68
PLI
CP group 3.00±0.22 2.59±0.57* 1.85±0.75*§ 0.41±0.52 1.15±0.73
CP+DM group 2.85±0.21# 2.42±0.58* 2.03±0.65*§ 0.43±0.52 0.81±0.65
WBC/(×109/L)
CP group 6.01±1.26 5.35±1.37* 5.51±1.51 0.66±1.11 0.50±1.18
CP+DM group 7.14±1.99# 6.57±1.68 6.00±1.37* 0.57±2.20 1.14±1.80
FBG/(mmol/L)
CP group 5.20±0.35 5.20±0.32 5.33±0.42 0.00±0.31 -0.13±0.47
CP+DM group 8.40±1.43# 7.72±1.40# 7.35±1.14*# 0.68±1.52# 1.05±1.59#
HbA1c/%
CP group - - - - -
CP+DM group 7.64±1.16 7.09±0.79* 7.06±0.78* 0.55±0.78 0.58±0.83

Table 3

GLMM analysis of WBC with clinical periodontal parameters and FBG"

Parameter β SE t/Z P 95%CI
Model 1
Intercept 3.19 0.77 4.12 <0.001 1.66 to 4.71
PD 0.57 0.22 2.56 0.011 0.13 to 1.00
FBG 0.28 0.09 3.25 0.001 0.11 to 0.45
Model 2
Intercept 3.37 0.99 3.39 0.001 1.41 to 5.33
PD 0.55 0.22 2.48 0.014 0.11 to 0.99
FBG 0.27 0.09 2.98 0.003 0.09 to 0.44
Model 3
Intercept 4.10 2.34 1.75 0.082 -0.52 to 8.72
PD 0.53 0.22 2.36 0.019 0.09 to 0.96
FBG 0.29 0.09 3.33 0.001 0.12 to 0.46
Model 4
Intercept 4.73 2.47 1.91 0.058 -0.16 to 9.61
PD 0.45 0.23 1.98 0.050 0.001 to 0.90
FBG 0.26 0.09 2.94 0.004 0.09 to 0.44
[1] Graves DT, Ding Z, Yang Y. The impact of diabetes on periodontal diseases[J]. Periodontol 2000, 2020, 82(1):214-224.
doi: 10.1111/prd.12318 pmid: 31850631
[2] Genco RJ, Graziani F, Hasturk H. Effects of periodontal disease on glycemic control, complications, and incidence of diabetes mellitus[J]. Periodontol 2000, 2020, 83(1):59-65.
doi: 10.1111/prd.v83.1
[3] Costa FO, Cota LM, Lages EP, et al. Progression of periodontitis and tooth loss associated with glycemic control in individuals undergoing periodontal maintenance therapy: A 5-year follow-up study[J]. J Periodontol, 2013, 84(5):595-605.
doi: 10.1902/jop.2012.120255
[4] Mirza RE, Fang MM, Weinheimer-Haus EM, et al. Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice[J]. Diabetes, 2013, 63(3):1103-1114.
doi: 10.2337/db13-0927
[5] da Cruz GA, de Toledo S, Sallum EA, et al. Clinical and laboratory evaluations of non-surgical periodontal treatment in subjects with diabetes mellitus[J]. J Periodontol, 2008, 79(7):1150-1157.
doi: 10.1902/jop.2008.070503
[6] Correa F, Goncalves D, Figueredo C, et al. The short-term effectiveness of non-surgical treatment in reducing levels of interleukin-1beta and proteases in gingival crevicular fluid from patients with type 2 diabetes mellitus and chronic periodontitis[J]. J Periodontol, 2008, 79(11):2143-2150.
doi: 10.1902/jop.2008.080132
[7] Goncalves D, Correa F, Khalil NM, et al. The effect of non-surgical periodontal therapy on peroxidase activity in diabetic patients: A case-control pilot study[J]. J Clin Periodontol, 2010, 35(9):799-806.
doi: 10.1111/cpe.2008.35.issue-9
[8] Vozarova B, Weyer C, Lindsay RS, et al. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes[J]. Diabetes, 2002, 51(2):455-461.
pmid: 11812755
[9] Zhang H, Zhen Y, Zhang W, et al. White blood cell subtypes and risk of type 2 diabetes[J]. J Diabetes Complications, 2016, 31(1):31-37.
doi: 10.1016/j.jdiacomp.2016.10.029
[10] NibaliI L, D’Aiuto F, Griffiths G, et al. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: A case-control study[J]. J Clin Periodontol, 2010, 34(11):931-937.
doi: 10.1111/cpe.2007.34.issue-11
[11] Wang X, Meng H, Xu L, et al. Mean platelet volume as an inflammatory marker in patients with severe periodontitis[J]. Platelets, 2015, 26(1):67-71.
doi: 10.3109/09537104.2013.875137
[12] Sonoki K, Nakashima S, Takata Y, et al. Decreased lipid peroxidation following periodontal therapy in type 2 diabetic patients[J]. J Periodontol, 2006, 77(11):1907-1913.
pmid: 17076618
[13] Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis[J]. J Clin Periodontol, 2007, 34(10):835-843.
pmid: 17850602
[14] 徐菁玲, 孟焕新, 李峥, 等. 牙周基础治疗对2型糖尿病伴慢性牙周炎患者血糖代谢指标及血清生化指标的影响[J]. 北京大学学报(医学版), 2013, 45(1):27-32.
[15] Suvan J, Harrington Z, Petrie A, et al. Obesity as predictive factor of periodontal therapy clinical outcomes: A cohort study[J]. J Clin Periodontol, 2020, 47(5):594-601.
doi: 10.1111/jcpe.13261 pmid: 31994205
[16] Retamal I, Hernandez R, Velarde V, et al. Diabetes alters the involvement of myofibroblasts during periodontal wound healing[J]. Oral Dis, 2020, 26(5):1062-1071.
doi: 10.1111/odi.v26.5
[17] Trombelli L, Simonelli A, Franceschetti G, et al. What periodontal recall interval is supported by evidence?[J]. Periodontol 2000, 2020, 84(1):124-133.
doi: 10.1111/prd.12340 pmid: 32844410
[18] Mauri-Obradors E, Merlos A, Estrugo-Devesa A, et al. Benefits of non-surgical periodontal treatment in patients with type 2 diabetes mellitus and chronic periodontitis: A randomized controlled trial[J]. J Clin Periodontol, 2018, 45(3):345-353.
doi: 10.1111/jcpe.12858 pmid: 29265454
[19] Shiny A, Bibin YS, Shanthirani CS, et al. Association of neutrophil-lymphocyte ratio with glucose intolerance: An indicator of systemic inflammation in patients with type 2 diabetes[J]. Diabetes Technol Ther, 2014, 16(8):524-530.
doi: 10.1089/dia.2013.0264
[20] Cersosimo E, Defronzo RA. Insulin resistance and endothelial dysfunction: The road map to cardiovascular diseases[J]. Diabetes-Metab Res Rev, 2010, 22(6):423-436.
doi: 10.1002/(ISSN)1520-7560
[21] Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes[J]. Diabetes Care, 2004, 27(1):216-222.
doi: 10.2337/diacare.27.1.216
[22] Gao H, Xu J, He L, et al. Calprotectin levels in gingival crevicular fluid and serum of patients with chronic periodontitis and type 2 diabetes mellitus before and after initial periodontal therapy[J]. J Periodont Res, 2021, 56(1):121-130.
doi: 10.1111/jre.v56.1
[23] Gao H, Hou J, Meng H, et al. Proinflammatory effects and mecha-nisms of calprotectin on human gingival fibroblasts[J]. J Periodont Res, 2017, 52(6):975-983.
doi: 10.1111/jre.2017.52.issue-6
[1] Lianfei PAN, Wenjing LI, Ruiyang WANG, Jian JIAO, Zhanqiang CAO, Li GAO, Dong SHI. Short-term efficacy and influencing factors of systemic antibiotics as an adjunct to mechanical periodontal therapy for stages Ⅲ/Ⅳ periodontitis [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 30-36.
[2] Rentao TANG, Liuchang YANG, Jie NIE, Xiaoyan WANG. Microbial communities in extraradicular infections of post-treatment apical periodontitis without or with sinus tracts [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 43-49.
[3] Siqiao ZHANG, Jian LIU, Tao XU, Wenjie HU, Haoyun ZHANG, Yiping WEI. Clinical comparison of xenograft versus synthetic bone graft materials in micro crestal flap-alveolar ridge preservation following extraction of molars [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 74-83.
[4] Hewei MIN, Yibo WU, Yuhui SHI, Mingzi LI, Xinying SUN. Analyzing the influential factors of dietary patterns and blood glucose control in type 2 diabetes patients based on the model of health action process approach model [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1145-1152.
[5] Jingyan GU, Xinyi LI, Jinxia ZHAO, Rong MU. Diabetic Charcot neuroarthropathy initially misdiagnosed as rheumatoid arthritis and gout: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1193-1197.
[6] Baojin MA, Jianhua LI, Yuanhua SANG, Yang YU, Jichuan QIU, Jinlong SHAO, Kai LI, Shiyue LIU, Mi DU, Lingling SHANG, Shaohua GE. Establishment and application of key technologies for periodontal tissue regeneration based on microenvironment and stem cell regulation [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 841-846.
[7] Pei CAO, Qingxian LUAN. Periodontitis and systemic diseases: Thinking and explorations [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 852-858.
[8] Zhenying BAO, Yajie WANG. Application of combined detection of inflammatory indexes and cytokines in chronic periodontitis [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 772-778.
[9] Ziyan CHEN, Xiaoyue ZHANG, Yiwu GU, Chun CHANG. Type 2 diabetes patients use E-health to manage disease willingness and influence mechanisms [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 522-528.
[10] Yutong SHI, Yiping WEI, Wenjie HU, Tao XU, Haoyun ZHANG. Evaluation of micro crestal flap-alveolar ridge preservation following extraction of mandibular molars with severe periodontitis [J]. Journal of Peking University (Health Sciences), 2025, 57(1): 33-41.
[11] Jingqian LI, Zilu ZHU, Jian JIAO, Jie SHI. Clinical efficacy of clear aligner treatment for pathologically migrated teeth in the anterior region of patients with severe periodontitis [J]. Journal of Peking University (Health Sciences), 2025, 57(1): 51-56.
[12] Yaqing MAO, Zhen CHEN, Yao YU, Wenbo ZHANG, Yang LIU, Xin PENG. Impact of type 2 diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1089-1096.
[13] Peiheng ZHANG, Ying GAO, Honghua WU, Jian ZHANG, Junqing ZHANG. Fulminant type 1 diabetes mellitus with acute pancreatitis: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 923-927.
[14] Yuru HU,Juan LIU,Wenjing LI,Yibing ZHAO,Qiqiang LI,Ruifang LU,Huanxin MENG. Relationship between short-chain fatty acids in the gingival crevicular fluid and periodontitis of stage Ⅲ or Ⅳ [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 332-337.
[15] Yujia MA,Ranli LU,Zechen ZHOU,Xiaoyi LI,Zeyu YAN,Yiqun WU,Dafang CHEN. Association between insomnia and type 2 diabetes: A two-sample Mendelian rando-mization study [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 174-178.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd